Skip to main content
S 566 109th Congress Senate Health Commerce Community health services Congress Congressional investigations Congressional reporting requirements Consumer education Cost control Drug utilization Drugs Economics and Public Finance Federal aid to health facilities Federal-state relations Finance and Financial Sector Government Operations and Politics Government paperwork Health counseling Health insurance Health maintenance organizations Health surveys

Medicare Dual Eligible Prescription Drug Coverage Act of 2005

Introduced: March 8, 2005 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 8, 2005
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S2271-2272)
Mar 8, 2005
Sponsor introductory remarks on measure. (CR S2270-2271)
Mar 8, 2005
Introduced in Senate
 Plain-English summary Congressional Research Service

Medicare Dual Eligible Prescription Drug Coverage Act of 2005 - Provides that, for prescriptions filled between January 1 and June 30, 2006, requirements for the coordination of prescription drug benefits with Medicare as primary payor for dual eligible individuals under the new prescription drug benefit program (PDP) under Medicare part E (Voluntary Prescription Drug Benefit Program) shall not apply. Requires a State to continue to provide Medicaid medical assistance with respect to prescription drugs as if such coordination requirements had not been enacted.

Declares that no State or the District of Columbia shall be required to pay (reimburse) the Secretary of Health and Human Services for Medicaid prescription drug costs for dual eligible individuals (Medicaid clawback payments) for any month before July 1, 2006.

Earmarks specified amounts for education and outreach to dual eligibles regarding prescription drug coverage and monitoring of their transition to prescription drug coverage under Medicare.

Requires a PDP sponsor and an MA organization offering an MA-PD plan to submit to the Secretary appropriate information regarding the drug utilization of enrollees in such plans who are full-benefit dual eligible individuals. Directs the Secretary to collect data on the drug utilization of full-benefit dual eligible individuals and share it with the States and District of Columbia in as close to a real-time basis as possible.

Directs the Comptroller General of the United States to study and report to Congress on the clawback formula.

What's happening now March 8, 2005

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S2271-2272)

 Committees of jurisdiction 1